Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Appl Toxicol. 2015 Apr 29;36(1):161–174. doi: 10.1002/jat.3157

Figure 3.

Figure 3

Association of mRNAs and miRNAs with IPA literature-based lung abnormalities. All significant mRNAs (FDR 10%, FC >1.5) and miRNAs (FDR 10%, FC >1.2) were input into IPA, and an IPA disease and functions overlay was used to determine their association with the IPA diseases idiopathic pulmonary fibrosis, inflammation of respiratory system, fibrosis of lung, lung cancer, and non-small cell lung adenocarcinoma